Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Treatment of status epilepticus: A survey of neurologists
Jan Claassen
, Lawrence J. Hirsch
,
Stephan A. Mayer
Research output
:
Contribution to journal
›
Article
›
peer-review
112
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of status epilepticus: A survey of neurologists'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antiepileptic Drugs
100%
Status Epilepticus
100%
Neurologist
100%
New-onset Refractory Status Epilepticus (NORSE)
75%
Phenytoin
50%
Fosphenytoin
50%
Phenobarbital
25%
Seizure
25%
Treatment Preferences
25%
Lorazepam
25%
Prospective Randomized Trial
25%
Epilepsy
25%
Randomized multicenter Trial
25%
Current Treatment
25%
Critical Care
25%
American Academy of Neurology
25%
Second-line Therapy
25%
Treatment Paradigms
25%
Continuous Infusion
25%
General Guidelines
25%
Pentobarbital
25%
Titration
25%
Traditional Treatment
25%
First-line Therapy
25%
Propofol
25%
Valproic Acid
25%
Antiepileptic Treatment
25%
Midazolam
25%
New Antiepileptic Drugs
25%
Fourth Line
25%
Burst Suppression
25%
Intravenous Lorazepam
25%
Electrical Status Epilepticus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
100%
Epileptic State
100%
Lorazepam
33%
Phenytoin
33%
Fosphenytoin Sodium
33%
Preference
33%
Pharmacotherapy
16%
Phenobarbital
16%
Elimination
16%
Midazolam
16%
Pentobarbital
16%
Propofol
16%
Sodium Valproate
16%
Neuroscience
Status Epilepticus
100%
Anticonvulsant
100%
Phenytoin
33%
Fosphenytoin
33%
Lorazepam
33%
Pentobarbital
16%
Phenobarbital
16%
Valproic Acid
16%
Propofol
16%
Midazolam
16%
Drug Therapy
16%